Galactooligosaccharide

Galactooligosaccharides (GOS), also known as oligogalactose, are a type of carbohydrate that are composed of short chains of galactose molecules. They are commonly used as a prebiotic dietary supplement and are found in a variety of foods, including legumes, whole grains, and certain fruits and vegetables.

Overview

Galactooligosaccharides are non-digestible food ingredients that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon, thus improving host health. They are produced from lactose, which is derived from cow's milk, through the enzymatic activity of β-galactosidase.

Health Benefits

GOS have been shown to have a number of health benefits, including promoting the growth of beneficial gut bacteria, improving mineral absorption, and enhancing the body's immune response. They may also help to reduce the risk of certain diseases, such as colon cancer and inflammatory bowel disease.

Gut Health

Galactooligosaccharides are a type of prebiotic, which means they feed the beneficial bacteria in the gut. This can help to improve gut health and digestion, and may also have benefits for the immune system.

Mineral Absorption

GOS have been shown to improve the absorption of minerals in the gut, including calcium and magnesium. This can help to support bone health and may also have benefits for cardiovascular health.

Immune Function

Research has shown that GOS can help to enhance the body's immune response, potentially helping to protect against infection and disease.

Safety and Side Effects

GOS are generally considered safe for consumption, although they can cause side effects in some people, including bloating, gas, and diarrhea. These side effects are usually mild and go away on their own with continued use.

See Also

• Prebiotics
• Probiotics
• Gut Health
• Digestive Health

Galactooligosaccharide Resources
Need Help Finding a Doctor? WikiMD's DocFinder can help find general and specialist physicians.	Latest articles Most recent articles Ongoing trials.